Clinical Trial

Assessment of Schizophrenia Patients' Clinical Study Experiences

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2023 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with schizophrenia who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all schizophrenia patients as well as those in under-represented demographic groups.
Trial Details
NCT Number NCT05948111
Lead Sponsor Power Life Sciences Inc.
Conditions Schizophrenia
Enrollment 500 participants
Start Date 2024-08
Primary Completion 2025-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2023-07-17